EA202192046A1 - SYSTEMS AND METHODS FOR EXTRACORPORAL HYPERTHERMAL PERFUSION (EHP) THERAPY - Google Patents

SYSTEMS AND METHODS FOR EXTRACORPORAL HYPERTHERMAL PERFUSION (EHP) THERAPY

Info

Publication number
EA202192046A1
EA202192046A1 EA202192046A EA202192046A EA202192046A1 EA 202192046 A1 EA202192046 A1 EA 202192046A1 EA 202192046 A EA202192046 A EA 202192046A EA 202192046 A EA202192046 A EA 202192046A EA 202192046 A1 EA202192046 A1 EA 202192046A1
Authority
EA
Eurasian Patent Office
Prior art keywords
ehp
therapy
extracorporal
systems
methods
Prior art date
Application number
EA202192046A
Other languages
Russian (ru)
Inventor
Герхард Зибенхюнер
Original Assignee
Зибенхюнер, Кристине
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зибенхюнер, Кристине filed Critical Зибенхюнер, Кристине
Publication of EA202192046A1 publication Critical patent/EA202192046A1/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Настоящее изобретение относится к системе для нагревания крови, в частности, для выполнения экстракорпоральной гипертермической перфузионной (EHP) терапии. Настоящее изобретение дополнительно относится к экстракорпоральной крови, нагретой выше нормальной температуры тела, для использования при лечении заболевания, выбранного из группы, состоящей из рака, аутоиммунного заболевания, инфекционного заболевания, воспалительного заболевания и сепсиса. Кроме того, настоящее изобретение относится к комбинации экстракорпоральной крови, нагретой выше нормальной температуры тела, и химиотерапевтического средства для использования при лечении рака.The present invention relates to a blood heating system, in particular for performing extracorporeal hyperthermic perfusion (EHP) therapy. The present invention further relates to extracorporeal blood heated above normal body temperature for use in the treatment of a disease selected from the group consisting of cancer, autoimmune disease, infectious disease, inflammatory disease, and sepsis. In addition, the present invention relates to a combination of extracorporeal blood heated above normal body temperature and a chemotherapeutic agent for use in the treatment of cancer.

EA202192046A 2019-01-24 2019-08-01 SYSTEMS AND METHODS FOR EXTRACORPORAL HYPERTHERMAL PERFUSION (EHP) THERAPY EA202192046A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19153556 2019-01-24
PCT/EP2019/070811 WO2020151841A1 (en) 2019-01-24 2019-08-01 System and methods for extracorporeal hyperthermia perfusion (ehp) therapy

Publications (1)

Publication Number Publication Date
EA202192046A1 true EA202192046A1 (en) 2021-11-11

Family

ID=65234421

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202192046A EA202192046A1 (en) 2019-01-24 2019-08-01 SYSTEMS AND METHODS FOR EXTRACORPORAL HYPERTHERMAL PERFUSION (EHP) THERAPY

Country Status (4)

Country Link
EP (1) EP3914312A1 (en)
DE (1) DE202019005458U1 (en)
EA (1) EA202192046A1 (en)
WO (1) WO2020151841A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022040376A2 (en) * 2020-08-21 2022-02-24 Verthermia Acquisition, Inc. Improved method and system for controlled hyperthermia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2371781C (en) * 1999-05-25 2008-07-22 Viacirq, Inc. Hyperthermia method and apparatus
WO2015123645A2 (en) * 2014-02-17 2015-08-20 Spearman Patrick Richard Systems and methods for treating blood
EP3531991A1 (en) * 2016-10-31 2019-09-04 Elmedix Bvba Whole-body hyperthermia system

Also Published As

Publication number Publication date
EP3914312A1 (en) 2021-12-01
WO2020151841A1 (en) 2020-07-30
DE202019005458U1 (en) 2020-10-23

Similar Documents

Publication Publication Date Title
Hong et al. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial
PH12019500504A1 (en) Individual difference information management system in dialysis treatment
MX2023006353A (en) Internal ultraviolet therapy.
Kasimov et al. Efficacy of modified hemosorbents user for treatment of patients with multi-organ insufficiency
JP2013507379A5 (en)
WO2015049688A3 (en) Patient-specific immunotherapy for treating heterogeneous tumors
EA202192046A1 (en) SYSTEMS AND METHODS FOR EXTRACORPORAL HYPERTHERMAL PERFUSION (EHP) THERAPY
BR112022010905A2 (en) ANTI-CD38 ANTIBODY FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION
MX2019006141A (en) Methods of treating inflammatory disorders with multivalent fc compounds.
Howell Second primary cancers and cardiovascular disease after radiation therapy. NCRP report no. 170
Broman et al. Intra-arterial perfusion-based therapies for regionally metastatic cutaneous and uveal melanoma
Lionnet et al. Iron restriction is an important treatment of hemoglobin SC disease
Panchenko et al. Cryotherapy as part of the post-stress disorder rehabilitation complex
Kwon et al. Acupuncture therapy for fever induced by viral upper respiratory tract infection (URTI) in military medical service: a case series
Yeh et al. Is the renoprotective effect of erythropoietin in chronic kidney disease a myth?
Budlovsky Finding the humanity: Learning to listen in emergency medicine
Chudakova et al. Effectiveness of antiviral therapy for acute respiratory viral infections in frequently ill children
Pakzad et al. Blood transfusions in severe burn patients: Epidemiology and predictive factors: Methodological issues
Minervini et al. Re: Renal Cancer Surgery for Patients Without Preexisting Chronic Kidney Disease: Is There a Survival Benefit for Partial Nephrectomy?
Ducharme-Crevier et al. Childhood stroke and congenital heart disease
Xiaonong et al. New insights into the diagnosis and treatment of hyperkalemia in patients with chronic kidney disease
Toh et al. Concomitant Limb Cryocompression And Scalp Cooling To Reduce Paclitaxel-Induced Neuropathy And Alopecia
UA104218U (en) Apparatus for extracorporeal blood hyperthermia
Yacob Clinical Microbiology and Infectious Diseases
de Bondeville 500 mL/min, blood flow rate of 350 mL/min, low flux dialyzers F6 and monitors Fresenius 4008 S), CVC filled with citrate. Platelet count revised (Fig. 1). In January 2014 (284 days after heparins dis